Design and Development of a Functional Plant-based Beverage Formulated According to the Main Nutritional Guides for Early Elderly Requirements to Improve Nutritional Status and Immunity for the Early Elderly People to Get Well-healthy Ageing
Launched by UNIVERSITY ROVIRA I VIRGILI · Jun 3, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • - Men or women ≥60 years old \<75 years old; Written informed consent provided prior to the sensory tasting study.
- Exclusion Criteria:
- • Type 2 diabetes
- • Chronic alcoholism
- • Early community-dwelling seniors
- • Failure to comply with study guidelines.
- • Selection criteria
- Volunteers will be recruited through several ways:
- • general databases of participants from previous clinical trials of the NFOC-Salut group
- • Leaflets with study information, as well as contact information, will be distributed in health centers, civic centers and social centers.
- • The information will be disseminated through brochures with contact information among the people who are registered in the IMSERSO to select those who meet the inclusion criteria according to the study population in order to reach the largest number of subjects possible.
About University Rovira I Virgili
The University Rovira i Virgili (URV) is a prestigious academic institution located in Tarragona, Spain, renowned for its commitment to research and innovation in various fields, including health sciences. With a strong emphasis on interdisciplinary collaboration, URV actively engages in clinical trials aimed at advancing medical knowledge and improving patient care. The university's research initiatives are supported by state-of-the-art facilities and a network of experienced professionals dedicated to conducting high-quality studies that adhere to ethical standards and regulatory guidelines. Through its clinical research endeavors, URV seeks to contribute to the development of new treatments and therapies, ultimately enhancing the health outcomes of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0